Mutual Funds Commodities Research Tax Planning IPO Our Team Contact Us  

| More

JK Lakshmi Cement - Q4FY22 Result Update - Strong performance; Valuations drive upgrade - Accumulate

Posted On: 2022-06-24 12:54:47 (Time Zone: IST)

Mr. Kamlesh Bagmar - Deputy Head of Research, Prabhudas Lilladher Pvt. Ltd.

Quick Pointers:

- Aided by low cost inventory, coal cost will be up marginally by 7-8% QoQ in Q1
- In January took price hike of Rs25-30/Rs15-20 per bag in North/East regions.
- Consolidated Net debt fell by 20% YoY to Rs6.5bn with 0.7x to FY23e EBITDA; Net debt free on standalone level

JK Lakshmi (JKLC) reported strong set of Q4FY22 earnings. EBITDA grew 3% YoY to Rs2.76bn, a beat of 30%/43% over our/consensus estimates (CE). The beat was primarily due to sharply lower costs which came at Rs3,885/t, up 7% YoY v/s our estimate of 17% increase at Rs4,255. Lower than expected increase in power & fuel cost (due to low cost inventory), cut in advertisement costs (not participated in IPL team sponsorship), absence of consultancy charges and higher provisions in 9MFY22 contributed to lower costs. While, realisations missed our estimate by 3% or Rs168/t.

We continue to maintain that JKLC's margins would remain capped at ~Rs800/t due to its high lead distance, elevated share of non-trade volumes and limited scope for cost reduction. Given the steep fall in stock price (down 40% since our rating downgrade in August 2021), stable performance on earnings, sound B/S and valuations restored back to attractive zone, we upgrade stock to Accumulate with TP of Rs570, EV/EBITDA of 7.0x FY24e.

Lower costs drove the beat despite miss on realisations: Sales volumes grew 8.3% YoY at 3.1mnt (PLe:3.2mnt). Realisations declined 1.8% QoQ/Rs90 (+4.6% YoY/Rs211) at Rs4,763/t (PLe:Rs4,930) due to flat cement realisations at Rs4,435 (PLe:Rs4,515) and unchanged non-cement revenue at Rs1.03bn. Subdued realisations were more than offset by lower energy and S,G &A costs. Power & fuel cost increased 40% YoY (up 10% QoQ) at Rs1,100/t, much below our estimate of Rs1,275. Other expenses fell 27% YoY/34% QoQ to Rs396/t (PLe:Rs570). Due to significantly lower costs, EBITDA/t declined marginally by 5% YoY (+48% QoQ) to Rs880 (PLe:Rs675). PBT grew 2% YoY to Rs2.2bn (PLe:Rs1.6bn, CE:Rs1.4bn). Due to higher than expected tax rate (51% v/s PLe:29%), Adj. PAT fell 42% YoY to Rs1.1bn (PLe:Rs1.1bn CE: Rs1.0bn).

Key highlights of earnings con-call: 1) Capex guidance of Rs7bn/Rs9bn for FY23e/FY24e in Udaipur cement works (UCWL) towards its 2.5mnt brownfield expansion having total outlay of Rs16.5bn 2) UCWL's capex will be funded in Debt: Equity mix of 2:1 3) Expansion will be commissioned by March-24 4) Consolidated net debt would increase by Rs1.5-2.0bn by FY24e due to capex in UCWL 5) Will spend Rs700-800mn in standalone operations, predominantly the maintenance capex 6) Share of pet coke reduced by 400bps QoQ to 56%; AFR's share expanded 400bps to 14% 7) Cement cost will increase by Rs200/t QoQ in Q2FY23, reflecting the current coal cost 8) Renewable power's share stands at 40% with the increase in Waste heat recovery plant's capacity by 43% to 33MW 9) MAT credit's balance stands at Rs2.6bn v/s Rs3.0bn in FY21 10) Share of trade sales remained stable at 55-56%.

Shares of JK Lakshmi Cement Limited was last trading in BSE at Rs. 414.60 as compared to the previous close of Rs. 417.20. The total number of shares traded during the day was 7265 in over 629 trades.

The stock hit an intraday high of Rs. 421.50 and intraday low of 411.55. The net turnover during the day was Rs. 3021169.00.

Click here to send ur comments or to

Disclaimer:The article above is a gist / extract of the original report prepared by the research firm / brokerage firm. This article is not to be considered as an offer to sell or a solicitation to buy any securities. This article is meant for general information only., its employees or owners or the research firms, its employees or owners won't be responsible for any liability that may arise from information, errors or omissions in these articles. or its employees or owners / the research firms or its employees or clients or owners may from time to time hold positions in securities referred in this article. For detailed research reports, please contact the concerned research firm directly.

Other Headlines:

Gladiator Stocks - Minda Industries - ICICI Direct

Reliance Industries - Company Update - In fine fettle amidst global uncertainty - BUY

Sector Update - Sugar - ICICI Direct

Initiating Coverage - Hindustan Aeronautics Ltd - ICICI Direct

Rallis India - Company Update - Margin pressure likely to persist in near term..!! - Upgrade to 'BUY'

Indoco Remedies - Q4FY22 Result Update - In-line quarter; strong revenue guidance for US & EU mkt - Upgrade to 'BUY'

Indraprastha Gas - Q4FY22 Result Update - Impressive performance - BUY

KEC International - Annual Report Analysis - Healthy outlook across business segment - Accumulate

Westlife Development - Q4FY22 Result Update - Approaching the tipping point; Buy for LT Gains

Reliance Research downgrades Bajaj Auto to Sell

NOCIL - Q4FY22 Result Update - Strong operating performance amidst challenges - BUY

Gujarat Gas - Company Update - Deftly negotiating through tough times - BUY

Orient Electric - Gaining market share via innovation: initiate with ADD - ICICI Securities

Manappuram Finance - Q4FY22 Result Update - Intense Competition Put Pressure on Yields - BUY

Derivatives Weekly View - June 24, 2022 - ICICI Direct

Stock Tales - Newgen Software - ICICI Direct

Weekly Report - June 25, 2022 - Mr. Mitul Shah - Head of Research at Reliance securities

Gladiator Stocks - Bosch - ICICI Direct

Management Meet Update - Sheela Foam - ICICI Direct

Gladiator Stocks - Mahindra & Mahindra - ICICI Direct

Banks - Modifications to PPI and its impact on cards - Negligible impact, if any, for stocks under coverage

LIC Housing Finance - Q4FY22 Result Update - Fixed rate liabilities could cushion NIM - BUY

Navneet Education - Q4FY22 Result Update - Growth levers in place - BUY

MPC Minutes: Jun-22: All eyes on inflation - Acuité Ratings

Nazara Technologies - Management Meet Update - Breaking through the ESports landscape - BUY

Sector update - Quick Service Restaurants - YES Securities

Would it be wise to invest in a home early in your career?

Dr. Reddy's Laboratories - Analyst Meet Update - Multiple growth initiatives - BUY

Dhanuka Agritech - Management Meet Update - 1Q likely to be subdued; all hopes pinned on the monsoons - BUY

BUY Ipca Laboratories - Q4FY22 Result Update - Weak exports; gradual recovery

Acuité expects India's current account deficit to widen to more than USD 90 bn in FY23 - Acuité Macro Pulse

Inflationary concerns will continue to weigh on the pace of economic revival in FY23 - Acuité Macroeconomic Performance index

City Union Bank - Q4FY22 Result Update - Asset quality on the mend - BUY

Banks - BNPL - Early results are not that exciting as yet - Kotak

Acuité expects FY23 GDP growth estimate at 7.5% - Acuité Macro Pulse - Growth - May-22 Edition

Base factor pushes up IIP in Apr-22 to an 8-month high - Acuité Ratings

India Strategy & Q4FY22 Review - Long term growth prospects to overshadow near term uncertainties

India Equity Strategy - Quarterly flipbook: Q4FY22-Cost inflation driving downgrades

FMCG - D2C is here to stay; omni-channel the way forward - HDFC Securities

Automobile Sector - Monthly Quick View - May'22 - Steady Performance Improvement, backed by Gradual Rural Recovery

BFSI - New normal rate cycle; brace for transmission effects - HDFC Securities

SBI Cards and Payment Services - BUY - TP Rs. 1260 - YES SECURITIES

RBI frontloads rate hike amid increased inflationary headwinds - Acuité Ratings

Monetary Policy June 2022 - Axis MF Views

RBI Monetary Policy View - Mr. Dhiraj Relli, MD & CEO, HDFC Securities

Monetary Policy - entering the red zone - Anuj Puri, ANAROCK

Mr. Murali Ramakrishnan, MD &CEO, South Indian Bank on RBI Monetary Policy

Comments on RBI's MPC Policy Jun'22 - Acuité Ratings

Views on RBI Monetary Policy - June 2022

Bayer Cropscience - Q4FY22 Result Update - Healthy all round performance - BUY

Website Created & Maintained by : Chennai Scripts
West Mambalam, Chennai - 600 033,
Tamil Nadu, India

disclaimer copyright © 2005 - 2020